Reproductive health brand Crysta raises Rs 10 Cr in Pre-Series A round

New Delhi: Crysta recently raised Rs 10 crore in a Pre-Series A funding round led by the family office of Ruchirans and Anuraag Jaipuria.

The investors also include several family fund including Mumbai-based Green Shots Capital and Alfa Ventures, Delhi-based Real Time Ventures and NGB Dx, Dubai-based Petrotech, Steel City Securities and angel investors Lalit Wadhwa, Dr Kriti Maroli amongst others.

A press statement from the company said Crysta is an end-to-end pregnancy and fertility platform that uses in-house technology to offer various diagnostic and screening services combined with regular counselling and clinical data management.

Crysta uses both biochemistry and molecular NGS with its own bioinformatics platform. The brand is gradually scaling up across all aspects of mother and child health.

"The Pre-Series A funding will help us in building an end-to-end reproductive health platform covering all relevant aspects of pregnancy and fertility care. The potential is huge in this segment, and the current round will allow us to scale up Crysta and our other capabilities across major cities. We are also preparing for the $10 million Series A round for a much larger expansion in the mother and child segment,” said Dheeraj Jain, Founder, Redcliffe Life Sciences.

"Crysta is an amazing disruption in the reproductive health segment. We believe in the team’s capabilities in using this funding to scale up their technology platform," said Ruchirans Jaipuria, MD, Jaipuria Beverages.